Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypophosphatemia: clinical consequences and management.

Steven M Brunelli1, Stanley Goldfarb

  • 1Renal-Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. steven.brunelli@uphs.upenn.edu

Journal of the American Society of Nephrology : JASN
|June 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative Effectiveness of Cinacalcet Taken at-Home Versus Three Times Weekly In-Center on Controlling Calcium, Phosphate, and Parathyroid Hormone Levels.

Hemodialysis international. International Symposium on Home Hemodialysis·2025
Same author

Predicting hospitalizations for patients with chronic kidney disease.

The American journal of managed care·2023
Same author

Use of incremental peritoneal dialysis: impact on clinical outcomes and quality of life measure.

Journal of nephrology·2023
Same author

Midodrine Is an Effective Therapy for Resistant Intradialytic Hypotension: CON.

Kidney360·2023
Same author

Dysnatremia and risk of bloodstream infection in dialysis patients.

Clinical kidney journal·2022
Same author

Utilization of Home Dialysis and Permanent Vascular Access at Dialysis Initiation Following a Structured CKD Education Program.

Kidney medicine·2022
Same journal

Variants to Functions to Therapeutic Strategies Toward Genomically Informed Care for Autosomal Dominant Polycystic Kidney Disease.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Personalizing Cardio-Kidney-Metabolic Therapy: Closer But Not There Yet.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Autosomal Dominant Tubulointerstitial Kidney Disease: My Kingdom for a Biomarker.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Beyond the Margin: Improving Noninferiority Trials of Kidney Transplant Immunosuppression.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Parathyroid Hormone Receptor 1 Facilitates Cyst Growth in Genetic Models of Autosomal Dominant Polycystic Kidney Disease.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Alanyl-tRNA Synthetase 1 and Cyst Growth in Autosomal Dominant Polycystic Kidney Disease.

Journal of the American Society of Nephrology : JASN·2026
See all related articles

Hypophosphatemia, or low serum phosphate, has unclear clinical effects. This review explores its impact on hospitalized, ambulatory, and renal disease patients, and discusses optimal phosphate repletion strategies.

Area of Science:

  • Nephrology
  • Internal Medicine
  • Clinical Biochemistry

Background:

  • Clinical consequences of hypophosphatemia are not well-defined.
  • Implications of low serum phosphate may differ across patient populations.
  • Understanding these differences is crucial for effective patient management.

Purpose of the Study:

  • To review the clinical implications of hypophosphatemia in specific patient groups.
  • To examine evidence on optimal phosphate repletion strategies.
  • To provide a comprehensive overview of hypophosphatemia management.

Main Methods:

  • Literature review and commentary on existing evidence.
  • Analysis of studies focusing on hypophosphatemia in acute hospitalization, chronic ambulatory settings, and advanced renal disease.

Related Experiment Videos

  • Synthesis of data on phosphorus repletion techniques.

    • Main Results:

    • Hypophosphatemia presents varied clinical challenges in different patient cohorts.
    • Evidence suggests distinct management approaches may be necessary.
    • Optimal repletion strategies require careful consideration of the underlying condition.

    Conclusions:

    • The clinical impact of hypophosphatemia necessitates tailored approaches based on patient context.
    • Further research is needed to clarify best practices for phosphate repletion.
    • This commentary synthesizes current knowledge to guide clinical decision-making.